25 May 2013
Keywords: bayer, opts, into, arris, tryptase, inhibitor, asthma
Article | 21 October 1996
Bayer has started development of a tryptase inhibitor for asthma which
was first identified by Arris Pharmaceutical. The move results ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 October 1996
28 October 1996
24 May 2013
© 2013 thepharmaletter.com